Navigation Links
MedeAnalytics Releases Analysis of Public Comments on ACO Proposed Rule

EMERYVILLE, Calif., June 13, 2011 /PRNewswire/ -- MedeAnalytics, a leading provider of healthcare performance management solutions, disseminated today a report which analyzes the leading healthcare constituencies' recommendations on the major factors of the accountable care organization (ACO) economic model as presented in the proposed rule for the Medicare Shared Savings Program.


The proposed rule was released on March 31, 2011, and the public comment period ended on June 6, 2011. The MedeAnalytics report identifies nine elements of the program that function as the primary drivers of the Medicare ACO business model. In addition, it presents the respective positions on these elements of seven nationally recognized healthcare constituencies: the American Hospital Association, the Federation of American Hospitals, the American Medical Association, the American Medical Group Association, the Medical Group Management Association, America's Health Insurance Plans, and Brookings-Dartmouth.

"While there has been some rhetoric in the media about scrapping the entire ACO program as laid out by the proposed rule, the seven constituent organizations presented recommendations to revise, not repeal, the program," commented Ken Perez, who directs MedeAnalytics' healthcare policy team and serves as the company's senior vice president of marketing.

All seven organizations recommended a significant reduction to the 65 quality measures in the proposed rule (with the 32 measures of the Physician Group Practice Demonstration often cited as a preferred measure set), as well as a gradual phase-in period. A majority of the organizations urged the Centers for Medicare & Medicaid Services (CMS) to make the financial terms of the ACO program more attractive, with calls for a standard, flat Minimum Savings Rate, increases to the maximum shared savings rate, the elimination of withholding of a portion of the earned performance payment by CMS, and creation of a separate model without downside risk.  

To download the complete report, including a table summarizing the recommendations of the seven organizations for the major financial aspects of the proposed rule, visit MedeAnalytics' ACO Resource Center at

About MedeAnalytics

Founded in 1994, MedeAnalytics delivers performance management solutions across the healthcare system—including hospitals, physician practices and payers—to ensure accountability and improve financial, operational and clinical outcomes. For more information, visit

For more information:
Bruce Lewis
Lewis & Summers Public Relations
(707) 813-1197

SOURCE MedeAnalytics
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. ACO Proposed Rule Simplified: MedeAnalytics Releases Comprehensive White Paper
2. Unprecedented international meeting releases preliminary vision for our energy future
3. ClearCanvas Releases First Commercial Version of Widely Used PACS; Integrated RIS/PACS to Follow
4. Announcement - Clontech Laboratories, Inc. Releases the iDimerize™ Cell Signaling and Expression Systems
5. ClearCanvas Releases First Commercial Version of Popular Clinical Radiology Workstation; PACS and RIS to Follow
6. BioLegend Releases Brilliant Violet 421™ Antibody Conjugates For Advanced Flow Cytometry Applications.
7. Clontech Laboratories, Inc. Releases the SMARTer™ Ultra Low RNA Kit for Illumina® Sequencing
8. OriGene Releases Bioactive Full-length Human MTOR Protein
9. Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2011
10. Waters Releases NuGenesis SDMS 7.1 Validated to Support Windows 7 and Empower 3 CDS
11. OriGene Releases 1500 TrueMAB™ Monoclonal Antibodies
Post Your Comments:
(Date:11/25/2015)... November 25, 2015 Studies reveal ... human plaque and pave the way for more effective treatment ... cats     --> ... diagnosed health problems in cats, yet relatively little was understood ... collaborative studies have been conducted by researchers from the WALTHAM ...
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... 2015 Cepheid (NASDAQ: CPHD ) today ... following conference, and invited investors to participate via webcast. ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ...      Tuesday, December 1, 2015 at 11.00 a.m. Eastern Time ... New York, NY      Tuesday, December 1, 2015 ...
(Date:11/24/2015)... 24, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ:  AEZS) (TSX: ... behalf of the Toronto Stock Exchange, confirms that as ... no corporate developments that would cause the recent movements ... --> About Aeterna Zentaris Inc. ... --> Aeterna Zentaris is a specialty biopharmaceutical company ...
Breaking Biology Technology:
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
(Date:11/10/2015)... Nov. 10, 2015 About ... that helps to identify and verify the identity ... considered as the secure and accurate method of ... a particular individual because each individual,s signature is ... especially when dynamic signature of an individual is ...
(Date:11/4/2015)... ALBANY, New York , November 4, 2015 /PRNewswire/ ... According to a new market report published by Transparency ... Size, Share, Growth, Trends and Forecast 2015 - 2022", ... value of US$ 30.3 bn by 2022. The market ... during the forecast period from 2015 to 2022. Rising ...
Breaking Biology News(10 mins):